Clinical Trial: A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of Alzheimer's Disease

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07905352) titled 'A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of Alzheimer's Disease' on Oct. 18.

Brief Summary: This study is a multicenter, randomized, double-Blind, placebo-controlled Phase 2 clinical study to evaluate the efficacy and safety of Simenafil Hydrochloride Tablets in the treatment of participants with Alzheimer's Disease

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Alzheimer Disease

Intervention: DRUG: Simenafil Hydrochloride Tablets 2.5 mg

Simenafil Hydrochloride Tablets 1 tablet (2.5mg/tablet) + Simenafil Hydrochloride Tablets placebo 1 tablet (10mg/tablet)

DRUG: Simenaf...